Gene Therapy for ACM Due to a PKP2 Pathogenic Variant
Clinical trial NCT06109181 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06109181
- Sponsor
- Lexeo Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-29
- Primary completion
- 2026-12-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.